candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract é seguro durante a gravidez?

Related ingredients

Frequently asked questions

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract é seguro durante a gravidez?

No harmonised CLP reproductive classifications (ECHA Annex VI) or SCCS/CIR reproductive contraindications were identified for microbial/yeast ferment extracts of the listed species; peer‑reviewed literature does not indicate teratogenicity or reproductive toxicity for topical use of such ferments. Cosmetic safety databases (CosIng/EWG) commonly list these as ferment extracts without reproduction flags, consistent with CIR precedent that cosmetic ferments are 'safe as used' when appropriately processed.

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract é seguro durante a amamentação?

No evidence from regulatory sources or peer‑reviewed studies suggests systemic reproductive toxicity or secretion into breast milk from topical application of these microbial ferment extracts; no harmonised classifications or SCCS/CIR warnings were found.

candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract é seguro para a pele do bebê?

Hazard and mechanism: no infant‑specific reproductive or developmental effects located. Exposure: dermal absorption from topical ferments is expected to be negligible in adults, but per guidance infant exposure scoring is increased by +1 due to higher surface‑area‑to‑weight and immature barrier, so exposure is assigned 1 for 0–3 yr skin even though systemic absorption is still expected to be low. Note: potential for topical sensitization or infection in severely immunocompromised infants is a general consideration but not a reproductive/developmental finding.

Como o VeriMom pontua candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract?

O VeriMom pontua candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.

Quais são as alternativas seguras a candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract na gravidez?

Veja nossa lista curada de alternativas seguras a candida (lactis-condensi/ robusta/utilis)/ debaryomyces/lactobacillus/leuconostoc/pichia/saccharomyces/streptococcus (cremoris/faecalis/lactis/thermophilus)/ torulaspora delbrueckii/zygosaccharomyces ferment extract com base em função semelhante e classificação sem riscos conhecidos.